REQUEST A DEMO
Total
USD $0.00
Search more companies

Boehringer Ingelheim Ilac Ticaret A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Boehringer Ingelheim Ilac Ticaret Anonim Sirketi Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Boehringer Ingelheim Ilac Ticaret A.S. is based in Turkiye, with the head office in Istanbul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 13, 1994. It currently has a total number of 321 (2026) employees. From the latest financial highlights, Boehringer Ingelheim Ilac Ticaret A.S. reported a net sales revenue increase of 94.48% in 2023. A growth of 62.33% was recorded in its total assets. The net profit margin of Boehringer Ingelheim Ilac Ticaret A.S. decreased by 0.7% in 2023.

Headquarters
Nidakule Levent Apartmani N:7-9-15 Esentepe Mahallesi Harman 1 Sokak Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Boehringer Ingelheim Ilac Ticaret A.S. report to view the information.

Website: http://www.boehringer-ingelheim.com.tr

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim Ilac Ticaret A.S. report to view the information.
Financial Auditors:
Purchase the Boehringer Ingelheim Ilac Ticaret A.S. report to view the information.
Incorporation Date:
July 13, 1994
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Boehringer Ingelheim Ilac Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
94.48%
Total Operating Revenue
94.48%
Operating Profit
-7.35%
Net Profit/Loss for the Period
38.75%
Total Assets
62.33%
Total Equity
49.96%
Operating Profit Margin
-9.31%
Net Profit Margin
-0.7%
Return on Equity (ROE)
-2.26%
Debt / Equity
6.27%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?